This presentation examines the status and features of R&amp;D and innovation of biotechnology (hereafter BT) in Korea, and discusses some implications. In order to do so, it looks into the , R&amp;D investment and human capital in BT as well as BT industry and government policy for BT in Korea. In addition, it identifies the Korean playerspsila R&amp;D activities such as R&amp;D objective, R&amp;D stage, internal/external/collaborative R&amp;D and technology acquisition channels through a Web-based large scale questionnaire survey conducted for a wide range of BT experts in companies, universities and public research institutes.
